NCT02873559 2024-05-29
PROGRESS
University Hospital, Gentofte, Copenhagen
Phase 2/3 Completed
Clinical Trials
7 trialsNCT00442533 2023-04-03
Safety and Efficacy Study of In-111 Pentetreotide to Treat Neuroendocrine Tumors
Radio Isotope Therapy of America
Phase 2/3 Completed
NCT03590119 2022-11-08
LUTIA
UMC Utrecht
Phase 2/3 Completed
NCT02608203 2022-10-14
GEP-NOC
Assistance Publique Hopitaux De Marseille
Phase 2/3 Completed
NCT04552847 2022-02-17
Al18F-NOTA-octreotide PET Imaging in Neuroendocrine Tumors
Universitaire Ziekenhuizen KU Leuven
Phase 2/3 Completed
NCT01379183 2016-03-21
Using Magnetic Resonance (MR) to Understand the Effect of Erythromycin on Bowel Motility
Mayo Clinic
Phase 2/3 Completed
NCT00997594 2015-04-28
Changes in Adrenal Hormones During Adrenal Radiofrequency Ablation
Mie University
Phase 2/3 Completed